Spectral assignments for the aldose reductase inhibitor 4(S)-2,3-dihydro-6-fluoro-2(R)-methylspiro[chroman-4,4′-imidazoline] -2′,5′-dione and its synthetic intermediates

Magnetic Resonance in Chemistry

Volumn 43, Issue 12, 2005, Pages 1008-1011

  Wang, Mingan ^a   Mishra, Manoj K ^a   Zhu, Wenjun ^a   Kador, Peter F ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

2D NMR; 13C NMR; 1H NMR; Aldose reductase inhibitor; C F and H F coupling constants; DEPT; Methylsorbinil

Indexed keywords

13C NMR; 1H NMR; 2-D NMR; ALDOSE REDUCTASE INHIBITORS; C-F AND H-F COUPLING CONSTANT; COUPLING CONSTANTS; DEPT; IMIDAZOLINES; METHYLSORBINIL; SYNTHETIC INTERMEDIATES;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

EID: 28644445086     PISSN: 07491581     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrc.1697     Document Type: Article

References (23)

1. Oka M, Kato N. J. Enzyme Inhib. 2001; 16: 465.
2. Oates PJ, Mylari BL. Expert Opin. Investig. Drugs 1999; 8: 2095.
3. Dvornik D. In Aldose Reductase Inhibition, Porte D (ed). McGraw-Hill: New York, 1987.
4. Kador PF. Med. Res. Rev. 1988; 8: 325.
5. Robison WG. In Animal Models of Diabetes a Primer Frontiers in Animal Diabetes Research, Sima AAF, Shafrir E (ed.) Harwood Academic Publishers: Amsterdam, 2000; 273.
6. Robison WG Jr, Laver NM, Lou MF In Progress in Retinal and Eye Research, Osborne NN. and Chader GJ (ed). vol. 14, Pergamon: Oxford, 1995; 593.
7. Kinoshita JH, Kador PF, Datiles MD. J. Am. Med. Assoc. 1981; 246: 257.
8. Demaine AG. Curr. Med. Chem. 2003; 10: 1389.
9. Chung SS, Chung SK. Curr. Med. Chem. 2003; 10: 1375.
10. Akagi Y, Takahashi Y, Tanabe T, Ikebe H, Majima K, Miyatani H, Miyamoto Y, Terubayashi H. Nippon Ganka Gakkai Zasshi 1987; 91: 187.
11. Dvornik D. J. Diabetes Complications 1992; 6: 25.
12. Neuenschwander H, Takahashi Y, Kador PF. J. Ocular Pharmacol. Ther. 1997; 13: 517.
13. Sato S, Mori K, Wyman M, Kador PF. Exp. Eye Res. 1998; 66: 217.
14. Cusick M, Chew EY, Ferris F, Cox TA, Chan C, Kador PF. Arch. Ophthalmol. 2003; 121: 1745.
15. Ueda K, Tanaka S, Kunii T, Kagei K, Sato T, Ono H, Ohtsuka I, Kawase M, Ohgoh T, Wakabayashi T. Fr. Demande 1982; FR2487353.
16. Kazuhide A. J. Pharm. Sci. 1989; 78: 256.
17. Asnizawa K, Uchikawa K, Hattori T, Sato T, Miyake Y. J. Pharm. Sci. 1988; 77: 635.
18. Privette TH, Heaslip RJ. PCT Int. Appl. 2002; WO2002098510.
19. Takenobu Y, Kamanaka Y, Obata T, Itou H. PCT Int. Appl. 2002; WO2004043491.
20. Dirlam NL, Moore BS, Urban FJ. J. Org. Chem. 1987; 52: 3587.
21. Urban FJ. US patent 4841079, 1989.
22. Miyajima G, Akiyama H, Nishmoto K. Org. Magn. Reson. 1972; 4: 811.
23. Frank JW, John DR. J. Am. Chem. Soc. 1971; 93: 2361.